Abstract 501: Discovery of BPI-460372, a potent and selective inhibitor of TEAD for the treatment of solid tumors harboring Hippo pathway aberrationsHongling Shen, Jiabing Wang, Hongfei Rong et al.|Cancer Research|2023Cited by 11